Cost minimization analysis of Herceptin subcutaneous versus Herceptin intravenous treatment for patients with HER2+ Breast cancer in Greece
Autor: | Mylonas, C., Skroumpelos, A., Fountzilas, G., Maniadakis, N. |
---|---|
Zdroj: | In Journal of Cancer Policy September 2017 13:11-17 |
Databáze: | ScienceDirect |
Externí odkaz: |